May 2018 | Volume 11, Issue 5
Activity Type: Journal Based CME™

Continuing Medical Education Program in Clinical Liver Disease
CME Information: Treatment of the Extrahepatic Manifestations of Chronic Hepatitis C infection

Educational Objective
Upon completion of this educational activity, participants will be better able to identify the extrehepatic complications from HCV.

Activity Disclosures
No commercial support has been accepted related to the development or publication of this activity.

Faculty Disclosures
Editor-in-Chief
: Nancy Reau discloses the following relevant financial relationship: honoraria received from Abbive, Abbott, and Gilead for her role as advisory/research; honoraria received from Merck for her role as consultant/research; consultation for BMS; honoraria to her institution from Genfit for research; and honoraria from Shire for research.

Guest Editor: Elizabeth J. May reported no conflicts of interest or financial relationships relevant to this article.

Question Author: Alan Bonder reported no conflicts of interest or financial relationships relevant to this article.

 

Associate Editors:
Danielle Brandman discloses the following relevant financial relationship: honoraria received from Alnylam for her role as consulting/advisory board.
Jessica Mellinger discloses the following relevant financial relationship: an unrestricted investigator initiated research grant from Salix for her role as PI.
Vlad Ratziu discloses the following relevant financial relationships: honoraria received from Allergan, Galmed, Genfit, Boehringer-Ingelheim, Pfizer, Enanta, Madrigal and NGM Bio for his role as consultant; research grant received from Gilead for investigator initiated research; and honoraria and research grant received from Intercept for consultancy and investigator initiated research.
Vicki Shah discloses the following relevant financial relationships: honoraria received from Gilead and Abbvie for her role as speaker/advisory board.
Michael Volk discloses the following relevant financial relationships: honoraria received from Esai, Inc and Biovie, Inc for his role in the advisory board.
Lisa VanWagner discloses the following relevant financial relationships: honoraria received from Salix for her role in the speakers bureau and grant received from Novartis for her role as coinvestigator.
Jospeh Ahn, Andrew Aronsohn, Murli Krishna, Jude Oben, Elizabeth Rand, and Jennifer Wells reported no conflicts of interest or financial relationships relevant to this article.

Authors: the authors reported no conflicts of interest or financial relationships relevant to this article.

This activity underwent peer review in line with the standards of editorial integrity and publication ethics. Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.

Accreditation

John Wiley and Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within 1 hour. To successfully earn credit, participants must complete the activity during the valid credit period, which is up to two years from initial publication. Additionally, up to 3 attempts and a score of 70% or better is needed to pass the post test.